Please use this identifier to cite or link to this item:
|Title:||Current views on the management of trophoblastic tumors|
|Authors:||Tham, K.F. |
|Keywords:||Gestational trophoblastic tumor|
|Citation:||Tham, K.F., Ratnam, S.S. (1995). Current views on the management of trophoblastic tumors. International Journal of Gynecology and Obstetrics 49 (SUPPL.). ScholarBank@NUS Repository. https://doi.org/10.1016/0020-7292(95)02413-7|
|Abstract:||Gestational trophoblastic disease has been recognized as a form of abnormal pregnancy as early as 1600 AD, and choriocarcinoma was the first cancer to be cured with chemotherapy even in the presence of distant and widespread metastases. Important advances in the past include the standardization of terminology, the concept of assignment of risk and the use of staging systems, the centralization of care and the establishment of regional registries, and of course the development of the radioimmunoassay for the beta subunit of human chorionic gonadotropin. The current views on the management of this disease recognizes the need for a multidisciplinary approach, with chemotherapy remaining at the forefront but also utilizing newer diagnostic techniques when necessary, and keeping in mind the crucial role that surgery can play especially in resistant cases. At the same time, the importance of basics such as careful follow up after evacuation of a hydatidiform mole cannot be overemphasized. There will be a continual refinement of the chemotherapy regimes used, and the aim is to achieve a similar level of response with decreased toxicity to the patient.|
|Source Title:||International Journal of Gynecology and Obstetrics|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jul 14, 2018
WEB OF SCIENCETM
checked on Jun 19, 2018
checked on Jul 13, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.